Trial Profile
Ferumoxytol as an MR contrast agent in CNS and head & neck tumors, intracranial and peripheral vascular disease
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Brain disorders; CNS cancer; Glioblastoma; Glioma; Head and neck cancer; Peripheral vascular disorders; Tumours
- Focus Diagnostic use
- 07 Mar 2016 New trial record